newsfilter
← Latest News
GlobeNewswire·

Exagen Inc. to Announce Fourth Quarter and Full Year 2025 Financial Results on March 10, 2026

CARLSBAD, Calif., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Exagen Inc. (NASDAQ:XGN), a leading provider of innovative autoimmune testing, will release financial results for the quarter ended December 31, 2025, before the